ArticlePDF Available

Zika Virus Outbreak on Yap Island, Federated States of Micronesia

Authors:

Abstract and Figures

In 2007, physicians on Yap Island reported an outbreak of illness characterized by rash, conjunctivitis, and arthralgia. Although serum from some patients had IgM antibody against dengue virus, the illness seemed clinically distinct from previously detected dengue. Subsequent testing with the use of consensus primers detected Zika virus RNA in the serum of the patients but no dengue virus or other arboviral RNA. No previous outbreaks and only 14 cases of Zika virus disease have been previously documented. We obtained serum samples from patients and interviewed patients for information on clinical signs and symptoms. Zika virus disease was confirmed by a finding of Zika virus RNA or a specific neutralizing antibody response to Zika virus in the serum. Patients with IgM antibody against Zika virus who had a potentially cross-reactive neutralizing-antibody response were classified as having probable Zika virus disease. We conducted a household survey to estimate the proportion of Yap residents with IgM antibody against Zika virus and to identify possible mosquito vectors of Zika virus. We identified 49 confirmed and 59 probable cases of Zika virus disease. The patients resided in 9 of the 10 municipalities on Yap. Rash, fever, arthralgia, and conjunctivitis were common symptoms. No hospitalizations, hemorrhagic manifestations, or deaths due to Zika virus were reported. We estimated that 73% (95% confidence interval, 68 to 77) of Yap residents 3 years of age or older had been recently infected with Zika virus. Aedes hensilli was the predominant mosquito species identified. This outbreak of Zika virus illness in Micronesia represents transmission of Zika virus outside Africa and Asia. Although most patients had mild illness, clinicians and public health officials should be aware of the risk of further expansion of Zika virus transmission.
Content may be subject to copyright.
original article
The
new england journal
of
me dicine
n engl j med 360;24 nejm.org june 11, 2009
2536
Zika Virus Outbreak on Yap Island,
Federated States of Micronesia
Mark R. Duffy, D.V.M., M.P.H., Tai-Ho Chen, M.D.,
W. Thane Hancock, M.D., M.P.H., Ann M. Powers, Ph.D.,
Jacob L. Kool, M.D., Ph.D., Robert S. Lanciotti, Ph.D., Moses Pretrick, B.S.,
Maria Marfel, B.S., Stacey Holzbauer, D.V.M., M.P.H.,
Christine Dubray, M.D., M.P.H., Laurent Guillaumot, M.S., Anne Griggs, M.P.H.,
Martin Bel, M.D., Amy J. Lambert, M.S., Janeen Laven, B.S., Olga Kosoy, M.S.,
Amanda Panella, M.P.H., Brad J. Biggerstaff, Ph.D., Marc Fischer, M.D., M.P.H.,
and Edward B. Hayes, M.D.
From the Division of Vector-Borne Infec-
tious Diseases, National Center for Zoo -
notic, Vector-Borne, and Enteric Diseases,
Centers for Disease Control and Preven-
tion (CDC ), Fort Collins, CO (M.R.D.,
A.M.P., R.S.L., A.G., A.J.L ., J.L., O.K., A.P.,
B.J.B., M.F., E.B.H.); the Epidemic Intelli-
gence Service Field Assignments Branch,
CDC, Atlanta (T.-H.C., S.H., C.D.); the
Wa’ab Community Health Center (W.T.H.,
M.B.) and the Yap State Department of
Health Service (M.M.) — both in Yap,
Federated States of Micronesia; the Of-
fice for the South Pacific, World Health
Organization, Suva, Fiji ( J.L.K.); the De-
partment of Health, Education, and So-
cial Affairs, Pohnpei, Federated States of
Micronesia (M.P.); and the Pasteur Insti-
tute, Noumea, New Caledonia (L.G.). Ad-
dress reprint requests to Dr. Fischer at
the Arboviral Diseases Branch, Division
of Vector-Borne Infectious Diseases, Cen-
ters for Disease Control and Prevention,
315 0 Ram par t Rd ., Fo rt C olli ns, CO 80 521 ,
or at mfischer@cdc.gov.
N Engl J Med 2009;360:2536-43.
Copyright © 2009 Massachusetts Medical Society.
ABSTR ACT
Bac kgro und
In 2007, physicians on Yap Island reported an outbreak of illness characterized by
rash, conjunctivitis, and arthralgia. Although serum from some patients had IgM
antibody against dengue virus, the illness seemed clinically distinct from previously
detected dengue. Subsequent testing with the use of consensus primers detected
Zika virus R NA i n t he serum of the patients but no dengue vir us or other a rboviral
RNA. No previous outbreaks and on ly 14 cases of Zika vi rus disease h ave been previ-
ously documented.
Methods
We ob t ai ned s e r um sa mples from pat ients a nd i nt e r vie wed pat i e nt s f or i n f o r m ation
on clinical signs and symptoms. Zika virus disease was confirmed by a finding of
Zika virus RNA or a specific neutralizing antibody response to Zika virus in the se-
rum. Patients with IgM antibody against Zika virus who had a potentially cross-reac-
tive neutralizing-antibody response were classif ied as having probable Zika virus
dise ase . We con ducted a house hold sur vey t o e st i m a t e t he pro port ion of Yap r esid e n t s
with IgM antibody against Zika virus and to identify possible mosquito vectors of
Zika virus.
Re sult s
We ident i f ied 49 conf irmed and 59 probable c ases of Zika vi rus disease. The patients
re s ided i n 9 o f t he 10 municip a lit ies on Yap. R a sh, f e ver, art h r alg ia, and c onjunc tiv it is
were common symptoms. No hospitalizations, hemorrhagic manifestations, or deaths
due to Zika virus were reported. We estimated that 73% (95% conf idence interval,
68 to 77) of Yap residents 3 years of age or older had been recently infected with Zika
virus. Aedes hensilli was the predominant mosquito species ident ified.
Conclusions
This outbreak of Zika virus illness in Micronesia represents transmission of Zika
virus outside Africa and Asia. Although most patients had mild illness, clinicians
and public hea lt h off icials should be awa re of the risk of fur ther expansion of Zi ka
virus transmission.
The New England Journal of Medicine
Downloaded from nejm.org on December 26, 2015. For personal use only. No other uses without permission.
Copyright © 2009 Massachusetts Medical Society. All rights reserved.
Zika Virus Outbreak on Yap Island
n engl j med 360;24 nejm.org june 11, 2009
2537
Z
ika virus is a flavivirus (family Flavi-
viridae) related to West Nile, dengue, and
ye llow fever vir uses.
1
Zika vi r us was isol at ed
in 1947 from a rhesus monkey in the Zika forest
near Entebbe, Uganda
2
; it s ge nome w as s equ en ce d
in 2006.
3
There is serologic evidence of human
Zika virus infection in Africa and Asia, and the
virus has been isolated from hu mans in Uganda,
Nigeri a, and Senegal.
2-12
Zika virus is believed to
be transmitted to hu mans by in fected mosquitoe s
and has been isolated from Aedes africanus, Aedes
luteocephalus, and Aede s aegypti.
13-16
No outbreaks
and only 14 cases of human Zika virus disease
have been previously documented.
2,12,17-19
Unti l
this outbreak, no transmission of Zika virus had
been reported outside of Africa and Asia.
In April and May 2007, physicians on Yap Is-
land, Federated States of Micronesia, noted an
outbreak of illness characterized by rash, conjunc-
tivitis, subjective fever, arthralgia, and arthritis.
Although t hree pat ients tested positive wit h a c om-
mercially available dengue IgM kit, the physicians
had the impression that this illness was clinically
distinct from dengue, which had been detected on
Yap in two previous outbreaks.
20,21
In June 2007,
serum from acutely ill patients was sent to the
Centers for Disease Control and Prevention (CDC)
Arbovirus Diagnostic and Reference Laboratory
in Fort Collins, Colorado. Ten of 71 samples (14%)
were found to contain Zika virus RNA according
to reverse-transcriptase–polymerase-chain-reaction
(RT-PCR) assay. RT-PCR assays with the use of
consen sus pr imers for nucleic acid of other a rbo-
viruses, including dengue, chikungunya, o’nyong-
nyong, Ross River, Barmah Forest, and Sindbis
viruses, were all negative. We conducted an inves-
tigation to define the epidemiologic features of t he
outbreak and to describe the clinical manifesta-
tions of Zika virus disease.
Methods
Set ting
The Federated States of Micronesia is an archi-
pelago nation located northeast of Papua New
Guinea. Yap State is the westernmost of the four
states of the country and comprises four closely
groupe d isl a nds a nd se veral o uter isla nds. This i n -
vestigation was conducted on the main group of
four islands, here referred to as Yap. Yap is approx-
imately 6 km wide by 15 km long with a popula-
tion of 7391 persons (2000 census data).
Ca se De finitio n and Find ing
We reviewe d med i c a l records a nd conducted pro-
spective surveillance at the hospital and all four
he alt h cent ers on Yap t o identi f y pat ient s wit h su s-
pected Zika virus dise ase dur ing t he period from
April 1 t hrough July 31, 2007. A patient with sus-
pected disease had acute onset of general ized m ac-
ul ar or papular rash, arthritis or a rthralgia, or no n-
purulent conjunctivitis. Patients with suspected
disease were asked to provide blood specimens
during the acute phase (i.e., within 10 days after
the onset of symptoms) and dur ing t he convales-
cent phase (i.e., 14 days later). We interviewed a
convenience sa mple of these pat ients w it h the use
of a st andard questionnaire to collect information
about demographic features, clinical signs and
symptoms, and the duration and severity of the
illness.
Labor atory Analysis and Case Cl assification
Serum samples were tested by enzyme-linked im-
munosorbent assay (ELISA) for IgM antibodies
against Zika virus and dengue virus.
22,23
Titers of
neutralizing antibody to Zika virus and dengue
virus were determined with the use of plaque-
reduction neutralizat ion tests with a cutoff value
of 90% ( PRNT
90
).
24
Serum sample s f rom patients
in the ac u t e phase we r e t e st e d by RT-PCR f or Zika
vir us and dengue virus RNA.
22,25
We considered a patient to have confirmed Zika
virus disease if Zika virus RNA was detected in
the serum or if all the following f indings were
present: IgM antibody against Zika virus (detected
by ELISA), Zika virus PRNT
90
titer of at least 20,
and a ratio of Zika virus PRNT
90
titer to dengue
virus PRNT
90
titer of at least 4. A patient was cl as-
sif ied as h aving probable Zi ka v i r us d ise ase if IgM
antibody against Zika virus was detected by ELISA,
Zika virus PRNT
90
titer was at least 20, the ratio of
Zika virus PRNT
90
titer to dengue virus PRNT
90
titer was less than 4, and either no Zika virus
RNA was detected by RT-PCR or the serum sam-
ple was inadequate for the performance of RT-PCR
(Fig. 1).
Household Survey
We surveyed the community to define the extent
of the outbreak and determine risk factors for in-
fection. We used simple, random, one-stage cluster
sampling to select 200 (16%) of the 1276 house-
holds on Yap, and we sought to enroll all house-
hold members 3 years of age or older. We used a
The New England Journal of Medicine
Downloaded from nejm.org on December 26, 2015. For personal use only. No other uses without permission.
Copyright © 2009 Massachusetts Medical Society. All rights reserved.
The
new england journal
of
me dicine
n engl j med 360;24 nejm.org june 11, 2009
2538
standard questionnaire to collect dat a from con-
senting household residents regarding age, sex,
bir t hpl ace, pot ential r i sk f actor s for infec t ion, and
il lness since Apr il 1, 2007. We obt ained blood sam-
ples from all eligible consenting household resi-
dents. Participants in whom IgM antibody against
Zika vi r us was detect e d by ELISA we re c onsi d e r e d
to have evidence of recent Zika virus infection.
Entomologic Investigation
Wat er-h oldi ng cont ai ner s and c ont ai ners w it h mo s-
qu i t o l a r vae or pup ae we r e count ed a t t he sur veyed
house holds. L a r vae and pupae we re co l lecte d a nd
identified. Adult mosquitoes were collected by light
traps, gravid traps, and aspiration at representa-
tive point s on Yap and were t h en pooled accor d i n g
to species, trap location, and collect ion date.
26,27
Pools of immature and mature mosquitoes were
tested by viral culture and by RT-PCR for Zika vi-
rus RNA for evidence of infection.
Statistical Analysis
The attack rates of Zika virus infection were cal-
culated with the use of 2000 census data for the
Federated States of Micronesia. Sur vey and surveil-
lance data were analyzed with t he use of SPSS soft-
ware, version 12.0, and S-Plus sof t ware, version 8.
For descriptive results, categorical variables were
gi ven as proport ion s and cont inuous variables were
described by the mean or the median and range.
For population inferences from the household
survey, standard errors, conf idence intervals, and
P values were calculated with the sampling design
taken into account and with the use of a finite
population correction.
28
Categorical variables f rom
the household sur vey were compared with the use
of the Rao and Scott correction to the chi-square
test. Standard calibration-weighted estimators were
used to adjust for nonresponse to the household
survey by calibrat ion to the Yap 2000 census popu-
lation according to 10-year age groups and sex for
the eligible population.
29
Inferences for the ento-
mologic survey were based on a simple random
sample of households, and the score confidence
interval was used for population binomial pro-
portions.
Results
Ca se Finding
We identif ied 185 cases of suspected Zika virus
disease. Of these, 49 (26%) were confirmed and
59 (32 %) were pr obable c a ses ( Fig. 1). Acute-phase
ser u m sample s wer e col lected w it hin 10 day s af t e r
the onset of illness f r om 45 of t he 49 pa t ients wit h
conf irmed dis ease (92%), and Zika virus R NA w as
de tect e d i n 15 of these 45 p at ient s (33%). No den-
gue virus RNA was detected in any of the 137 acute-
phase serum samples tested (45 of these 137 pa-
tients had confirmed Zika virus disease, 51 had
probable disease, and 41 had suspected disease).
The date of symptom onset among patients
39p6
185 Patients sought health care and met the case
definition for suspected Zika virus disease
Presence of Zika virus RNA
or
presence of IgM antibody against
Zika virus and Zika virus
PRNT90 ≥20 and Zika virus
PRNT90 : dengue virus PRNT90
ratio ≥4
No serologic or PCR evidence
of Zika virus infection
with
serum sample collected ≥10 days
after symptom onset
49 Had confirmed Zika
virus disease 5 Did not have Zika virus disease
Absence of Zika virus RNA
and
presence of IgM antibody against
Zika virus and Zika virus
PRNT90 ≥20 and Zika virus
PRNT90 : dengue virus PRNT90
ratio <4
59 Had probable Zika
virus disease
No serologic or PCR evidence
of Zika virus infection
and
no serum sample collected
≥10 days after symptom onset
72 Had suspected Zika
virus disease
AUTHOR:
FIGURE:
JOB: ISSUE:
4-C
H/T
RETAKE
SIZE
ICM
CASE
EMail Line
H/T
Combo
Revised
AUTHOR, PLEASE NOTE:
Figure has been redrawn and type has been reset.
Please check carefully.
REG F
Enon
1st
2nd
3rd
Duffy (Fischer)
1 of 4
06-11-09
ARTIST: ts
36024
Figure 1. Case Classification of 185 Patients Who Sought Health Care and Met the Case Definition for Suspected Zika Virus Disease
on Yap during the Period from April through July 2007.
The presence of Zika virus RNA was determined by reverse -transcriptase–polymerase-chain-reaction (RT-PCR) assay. PRNT
90
denotes
plaque-reduction neutralization test with a cutoff value of 90%.
The New England Journal of Medicine
Downloaded from nejm.org on December 26, 2015. For personal use only. No other uses without permission.
Copyright © 2009 Massachusetts Medical Society. All rights reserved.
Zika Virus Outbreak on Yap Island
n engl j med 360;24 nejm.org june 11, 2009
2539
wit h conf irmed or probable disease ranged from
April 15 to July 14 (Fig. 2). The number of cases
peaked in late May and subsided in early July. The
median age of patients with confirmed or probable
disease was 36 years (range, 1 to 76); 66 of these
patients (61%) were female.
The overall attack rate for conf irmed and prob-
able Zika virus disease detected among patients
presenting to health care facilities was 14.6 per
1000 Yap residents. The at t ack rates ra nged from
3.6 per 1000 population in both the Kanifay and
the Gilman municipalit ies to 21.5 per 1000 popu-
lation in Tomil municipality (Fig. 3). The sex-spe-
cif ic attack rates were 17.9 per 1000 females and
11.4 per 10 00 m ales. Cases occu rred among all a ge
groups, but the incidence of confirmed and prob-
able Zika virus disease detected by health care
sur vei llance was highest among persons 55 to 59
years of age (Fig. 4).
Of 49 patients with confirmed Zika virus dis-
ease, 31 (63%) provided information regarding
symptoms and exposures. The age and sex distri-
butions of these 31 patients were similar to those
of the remaining 18 patients with confirmed dis-
ease. The most commonly reported symptoms
were rash, fever (measured or repor ted), arthrit is
or arthralgia, and conjunctivitis (
Table 1
). Other
symptoms included myalgia, headache, retro-
orbital pain, edema, and vom iting. Twent y pat ient s
(65%) reported a subjective fever; the body tem-
perature of 12 of t hese pat ients was measured by
a health care provider, and none of the recorded
temperatures were above 37.9°C. The median du-
ration of rash was 6 days (range, 2 to 14), and
that of a r t h ralg ia was 3.5 d ays (range, 1 to 14). No
deaths, hospitalizations, or hemorrhagic compli-
cations were associated with Zika virus illness
during t h is out bre a k. None of t he 31 pat ients who
reported symptoms had traveled outside of Yap
within 2 weeks before the onset of symptoms.
Household Survey
Surveys were completed in 173 of 200 randomly
se lected house hol ds (86%). The 173 enrolled hous e-
holds had 852 residents, and t he med ian number
of re sident s per household wa s 5 (ra nge, 1 t o 18).
Forty-four residents were under 3 years of age and
therefore were not eligible to participate in the
su r ve y.
We obtained blood samples from 557 of the
808 eligible residents (69%). The age and sex dis-
tributions of the participants differed signif icant ly
from those of the eligible Yap population record-
ed in the 2000 census (P<0.001). Children from
3 through 9 years of age were underrepresented,
and adults 40 years of age or older were overrep-
resented in the survey in comparison with the
census population. Overall, males were underrep-
resented and females were overrepresented, al-
though the ratio of male to female participants
varied according to age group.
Among t he 557 household residents who pro-
vided blood samples, 414 (74%) had IgM antibody
against Zika virus, and 156 of these 414 persons
(38%) reported an illness during the outbreak pe-
riod that met the def inition of suspected Zi ka v i r us
disease. However, among the 143 participants who
provided blood samples and had no detectable
IgM antibody against Zika virus, 27 (19%) also
reported an illness that met the definition for sus-
pected Zika virus disease. Thus, among the survey
participants who were positive for IgM antibody
against Zika virus, a total of 19% (38% 19%) re-
ported a clinical illness that was probably attrib-
utable to Zika virus infection.
We used the household survey data to calculate
population estimates after accounting for sam-
pling design and nonresponse; these population
estimates differ slightly from the crude survey re-
sults. We estimated that 5005 of the 6892 Yap
residents who were 3 years of age or older (95%
confidence interval [CI], 4702 to 5308) were in-
fected with Zika virus during the outbreak, an
infection rate of 73% (95% CI, 68 to 77). An esti-
mated 919 residents (95% CI, 480 to 1357), or 18%
22p3
Week of Onset of Illness
No. of Cases
30
35
25
20
10
5
15
0
April 1
April 8
April 15
April 22
April 29
May 6
May 13
May 20
May 27
June 3
June 10
June 17
June 24
July 1
July 8
July 15
July 22
July 29
AUTHOR:
FIGURE:
JOB:
4-C
H/T
RETAKE
SIZE
ICM
CASE
EMail Line
H/T
Combo
Revised
AUTHOR, PLEASE NOTE:
Figure has been redrawn and type has been reset.
Please check carefully.
REG F
Enon
1st
2nd
3rd
Duffy (Fischer)
2 of 4
06-11-09
ARTIST: ts
36024 ISSUE:
Probable cases (N=59) Confirmed cases (N=49)
Figure 2. Confirmed and Probable Cases of Zika Virus Disease on Yap
among Persons Seeking Health Care, According to Week of Onset of Illness
during the Period from April through July 2007.
The New England Journal of Medicine
Downloaded from nejm.org on December 26, 2015. For personal use only. No other uses without permission.
Copyright © 2009 Massachusetts Medical Society. All rights reserved.
The
new england journal
of
me dicine
n engl j med 360;24 nejm.org june 11, 2009
2540
of t hose infected (95% CI, 10 to 27), had a clin ical
illness that was probably attributable to Zika vi-
rus. Therefore, the estimated ratio of the number
of residents with illness attributable to Zika virus
to the number of residents who were eit her asy mp-
tomatic or who had illness that could not be at-
tributed to Zika virus was 919:4086, or 1:4.4 (95%
CI, 1:4.3 to 1:4.6).
Male participants were more likely than female
participants to have IgM antibody against Zika
virus (77% [95% CI, 72 to 83] vs. 68% [95% CI,
62 to 74]; relative risk, 1.1 [95% CI, 1.0 to 1.2]).
The seroprevalence of IgM antibody against Zika
virus did not vary significantly across age groups
(P = 0.10). We found no behavioral or environmen-
tal risk factors for Zika virus infect ion. People who
reported an i llness consistent wit h suspected Zika
virus infection were significantly more likely to
have IgM antibody against Zika virus than those
who did not report such illness (P<0.001).
Entomologic Investigation
Of the 1366 water-holding containers identified
during the household survey, 587 (43% [95% CI,
40 to 46]) were infested with mosquito larvae or
pupae; infested containers were found at 148 of
the 170 household s surveye d (87% [95% CI, 81 to
91]). A total of 12 mosquito species belong ing to
four genera were identified; 9 species were iden-
tif ied by examination of larvae, and an additional
3 species were collected as adults. Aedes hensilli
was the predominant species identified and was
present in 489 of the water-holding containers
(36% [95% CI, 33 to 38]). No other species was
present in more than 3% of the containers. No
virus or viral nucleic acid could be detected in
any mosquito pool.
Discussion
In this Zika virus outbreak, approximately three
quar ters of Yap resident s were infected w ith Zi ka
virus, and we est imated that more than 900 peo-
ple had i l lness at t r ibut able t o Zika virus in fect ion.
Zika virus infection was widespread across all geo-
graphic areas of Yap and caused relatively mild
il l ness last i ng several d ays. There were no de aths
or hospitalizations attributed to Zika virus. We
were unable to detect Zika virus in any mosquito
sa m p l e s, a n d t here f ore we c an not d e te r mi ne w it h
ce r t ai nt y t he vector o f t r a n s m i ssio n. On t he b a sis
of the relative abundance of Aedes hensilli and pre-
vious evidence that this species was the most
likely vector of dengue virus transmission on
Yap, it is plausible that Aedes hensilli was a vector
of Zika virus transmission in t his outbreak.
21
The clinical signs and symptoms of Zika virus
infection were consistent with those described in
a previous report of one male patient but differ-
ent from those described in a previous case se-
ries.
2,20
In that case series, rash or conjunctivitis
was not reported and ar t h ralgia was noted in only
one of seven patients. Fever was reported in all
seven pat ients, but the study included only pat ients
who were hospitalized with febrile illness.
19
The detection of Zika virus R NA in the serum
of acutely ill patients and the absence of nucleic
acid of other arboviruses provide convincing evi-
dence t hat the outbreak was caused by Zika virus.
Although the transmission of dengue virus is com-
mon in Micronesia, none of the 137 patients for
whom acute-phase specimens were available had
evidence of dengue virus RNA in their serum.
21,22
Figure 3. Attack Rates for Conf irmed and Probable Zika Virus Disease
per 1000 Population According to Municipality on Yap during the Period
from April through July 2007.
The New England Journal of Medicine
Downloaded from nejm.org on December 26, 2015. For personal use only. No other uses without permission.
Copyright © 2009 Massachusetts Medical Society. All rights reserved.
Zika Virus Outbreak on Yap Island
n engl j med 360;24 nejm.org june 11, 2009
2541
All 108 patients with confirmed or probable Zika
virus disease had IgM antibody against Zika virus
and neutralizing antibodies. ELISA for IgM is a
relatively sensit ive and specif ic assay for detecting
arboviral infections.
23
Although the ELISA for IgM
antibody against Zika virus may cross-react with
IgM against other f laviviruses, such as dengue vi-
rus or yellow fever virus, it is not likely to cross-
react with IgM against alphaviruses such as chi-
kungunya or Ross River viruses. PRNTs effectively
discriminate among different primary flavivirus
infections, but patients who have secondary infec-
tions (those who have been previously vacci nated
against or exposed to another flavivirus) may have
indeterminate PRNT results.
30,31
The patients with
confirmed Zika virus disease had titers of neu-
tralizing antibodies against Zika virus that were
at least four times as high as their titers of neu-
tralizing antibodies against dengue virus, a f ind-
ing that provides strong evidence of primar y Zika
virus infection. The patients with probable Zika
virus disease also had neutralizing antibodies
against Zika virus, but the titers were less than
four times as high as the titers of neutralizing
antibodies against dengue virus. Although the re-
sults from these patients do not def initively con-
firm Zika virus infect ion, they are consistent with
Zika virus infection after a previous dengue virus
infection.
The at t ack rates of Zika vir us disease detected
by surveillance were higher among females than
males and among older persons than younger per-
sons. I n cont rast, t he pre valenc e of Ig M ant ibo dy
against Zika virus detected by the survey was
higher in male participants (perhaps because of
the possibility of their greater exposure to mos-
qu itoes) and was r elativel y even ly d istribu t ed across
age groups. These discrepancies may be because
of differences in healt h care–seeking behavior for
this relatively mild illness. The estimated ratio of
symptomatic to asymptomatic patients with Zika
virus infection in this outbreak is similar to that
described for West Nile virus infection.
32,33
We think it unlikely that Zika virus circulated
unrecognized on Yap before this outbreak. The
compact clustering of cases in May and June and
the high seroprevalence of IgM antibody against
Zika virus are consistent with an acute outbreak
of Zika virus illness in a populat ion wit hout pre vi-
ous immunity to Zika virus. Although precise est i-
mates of the persistence of IgM antibody against
Zika virus are not available, IgM antibodies to
dengue virus generally do not persist longer t han
90 days.
33
IgM antibodies to West Nile virus typi-
cally persist for about 5 months.
34-36
There were
no reports of widespread disease outbreaks on Yap
in t he 2 years before this outbreak. These results
support the conclusion that t h is outbreak resulted
from a recent introduction of Zika virus.
Zika virus might have been introduced to Yap
by a viremic nonhuman primate (monkeys live on
nearby Palau but not on Yap), but there were no
reports of any importation or recent arrival of non-
human primates. No other nonprimate vertebrates
or birds a re k nown t o be re ser voirs of Zik a vi r us;
unless ev idence of such a reservoir is discovered,
introduction of Zika virus through an infected
22p3
Attack Rate (per 1000 population)
50
60
40
30
10
20
0
0–4
5–9
10–14
15–19
20–24
25–29
30–34
35–39
40–44
45–49
50–54
55–59
≥60
AUTHOR:
FIGURE:
JOB:
4-C
H/T
RETAKE
SIZE
ICM
CASE
EMail Line
H/T
Combo
Revised
AUTHOR, PLEASE NOTE:
Figure has been redrawn and type has been reset.
Please check carefully.
REG F
Enon
1st
2nd
3rd
Duffy (Fischer)
4 of 4
06-11-09
ARTIST: ts
36024 ISSUE:
Age (yr)
Probable cases (N=59) Confirmed cases (N=49)
Figure 4. Attack Rates for Conf irmed and Probable Zika Virus Disease
on Yap According to Age Group during the Period from April through
July 2007.
Table 1. Clinical Characteristics of 31 Patients with Confirmed Zika Virus
Disease on Yap Island during the Period from April through July 2007.
Sign or Symptom No. of Patients (%)
Macular or papular rash 28 (90)
Fever* 20 (65)
Arthritis or arthralgia 20 (65)
Nonpurulent conjunctivitis 17 (55)
Myalgia 15 (48)
Headache 14 (45)
Retro-orbital pain 12 (39)
Edema 6 (19)
Vomiting 3 (10)
* Cases of measured and subjective fever are included.
The New England Journal of Medicine
Downloaded from nejm.org on December 26, 2015. For personal use only. No other uses without permission.
Copyright © 2009 Massachusetts Medical Society. All rights reserved.
The
new england journal
of
me dicine
n engl j med 360;24 nejm.org june 11, 2009
2542
nonprimate vertebrate seems unlikely. It is more
likely that Zika virus was introduced by an in-
fected mosquito or a viremic human. We did not
find any recently ill residents who had traveled
outside of Yap, but the virus could have been im-
ported by a person with undetected infection. Se-
rolo g ic e v idence of Zi k a virus i n fection in humans
has been reported in the Philippines, and travel
between Yap and the Philippines is common.
The accessibi lit y of ai r travel and the abund a nce
of mosquito vectors of f lavivirus in the Pacif ic re-
gion raise concern for the spread of Zika virus to
other islands in Oceania and even to the Americ as.
The pot ent i a l for such spread i s illust rate d by the
following anecdote. A medical volunteer visited
Yap from June 17 to June 29, 2007, and had onset
of symptoms meeting the case definition of sus-
pected Zika virus disease on July 7, 2007, after her
ret urn to the United States. She had IgM antibody
against Zika virus and neutralizing antibody in
her serum on July 20, indicating she had been in-
fected with Zika virus on Yap and was probably
viremic after arrival in the United States. The
emergence of Zika virus as an important human
pathogen on Yap in 2007 underscores the ease
with which exotic pathogens are transported be-
tween continents and the need for clinical vigi-
lance and strong epidemiologic and laboratory
surveillance systems to detect the spread of infec-
tious diseases.
No potential conflict of interest rele vant to t his article was
reported.
The views e xpressed are those of t he aut hors and do not nec-
essar ily represent the views of the Department of Health and
Human Services.
We t hank the physicians and st af f at t he Wa’ab Communit y
Health Centers, t he Yap State Depa rtment of Healt h Ser vice, the
Federated States of Micronesi a Depar tment of Health, Education,
and Social Affairs, the CDC Arbovira l Diseases Branch Diagnostic
and Reference Laborat ory, and the CDC Global Disease Det ection
Program for thei r support and assistance wit h this investigation.
References
Kuno G, Chang GJ, Tsuchiya KR,
1.
Karabatsos N, Cropp CB. Phylogeny of the
genus Flav iv ir us. J Virol 1998;72:73-83.
Simpson DI. Zika virus infect ion in 2.
man . Tra ns R Soc Tr op Me d Hyg 1964;58:
335-8 .
Kuno G, Chang GJ. Full-length se-3.
quencing and genomic characterization of
Ba gaza, Ked ou gou , an d Zi ka v ir use s. A rch
Virol 2007;152:687-96.
Pond WL. A rthropod-bor ne virus ant i-4.
bod ies in ser a f rom reside nt s of sout h-east
Asia. Trans R Soc Trop Med Hyg 1963;57:
36 4 -71 .
Smithburn KC. Neutralizing antibod-5.
ie s a gai nst ar thropo d-bo rne vi rus es in t he
sera of long-time residents of Malaya and
Borneo. Am J Hyg 1954;59:157-63.
Ja n C, L angui ll at G, Ren aude t J, Ro bin Y. 6.
A serolog ical sur vey of arbovirus es i n Ga-
bon . Bul l S oc Path ol Exot F il iale s 1978;7 1:
140-6. (In French.)
Adekolu-John EO, Fagbami AH. Ar-7.
thropod-borne virus antibodies in sera of
re si de nt s of Ka in ji La ke B as in , N ige ri a 1 98 0.
Trans R Soc Trop Med Hyg 1983;77:149-
51.
Darwish MA, Hoogstraa l H, Roberts 8.
TJ, Ah med IP, Om ar F. A se ro -ep idem io log -
ical survey for certai n arbovir uses (Toga-
viridae) in P akistan. Tra ns R Soc Trop Med
Hy g 198 3;77: 442- 5.
Olson JG, Ksiazek TG, Gubler DJ, et 9.
al. A sur vey for arboviral antibodies in
sera of hum ans and animals in Lombok,
Republic of Indonesia. Ann Trop Med
Parasitol 1983;77:131-7.
Monlun E, Zeller H, Le Guenno B, et 10.
al. Sur veill an ce o f the circ ul at ion of a rb o-
virus of medical interest i n t he region of
ea ste rn Sen ega l. Bul l S oc Pat hol E xot 1 993;
86:21-8. (In French.)
Fagbami A. Epidemiologica l investiga-11.
tions on a rb ov ir us in fe ct ions a t Igbo-Ora,
Nigeria. Trop Geogr Med 1977;29:187-91.
Mo ore DL, Cau sey OR, Ca re y DE, e t al. 12.
Art hropod-borne viral in fect ions of man
in Nigeria, 1964-1970. Ann Trop Med
Parasitol 1975;69:49-64.
Gubler D, Kuno G, Markof f L. Flavivi-13.
ruses. In: Knipe D, Howley P, eds. Fields
virology. 4th ed. Philadelph ia: Lippincot t-
Raven, 2001:1152.
Dick GW. Zika vi ru s. II. Pat hogenicity 14.
and phy sica l pr operti es. Tra ns R So c Trop
Med Hyg 1952;46:521-34.
Lee VH, Moore DL. Vectors of the 15.
1969 yellow fever epidemic on the Jos Pla-
teau, Nigeria. Bull World Health Organ
1972;46:669-73.
Marchet te NJ, Garcia R, Rudnick A. 16.
Isolat ion of Zik a vir us from Aede s aegypt i
mosquitoes in Ma laysia. Am J Trop Med
Hyg 1969;18:411-5.
Fagbami AH. Zika virus infections in 1 7.
Nigeria: virological and seroepidem iolog-
ical investigations in Oyo State. J Hyg
(Lond) 1979;83:21 3-9.
Fi lipe A R, Ma rtin s CM, Ro cha H . Lab-18.
or ato ry infe ct ion wit h Zik a virus af ter vac -
cinat ion against yel low fever. Arch Gesa-
mte Virusforsch 1973;43:315-9.
Olson JG, Ksiazek TG, Suhandiman, 19.
Triwibowo. Zika virus, a cause of fever in
Central Java, Indonesia. Trans R Soc Trop
Med Hyg 1981;75:389-93.
Durand MA, Bel M, Ruwey I, Mar fel 20.
M, Yug L, Ngaden V. An outbreak of den-
gue fever i n Yap St ate. Pac He alth Dialog
2005;12:99-102.
Savage HM, Fritz CL, Rutstein D, Yol-21.
wa A, Vorndam V, Gubler DJ. Epidemic of
dengue-4 v irus in Yap State, Federated
States of Micronesia, and implication of
Aedes hensilli as an epidemic vector. Am J
Trop Med Hyg 19 98;58:519 -24.
Lanciotti RS, Kosoy OL, Laven JJ, et al. 22.
Genetic and serologic properties of Zika
virus associated with an epidemic, Yap
State, Micronesia, 2007. Emerg Infect Dis
200 8;14:1232-9.
Mart in DA, Muth DA, Brown T, John-23.
son AJ, Karabatsos N, Roehrig JT. Stan-
dardizat ion of immu nog lobu lin M capture
enzy me-lin ked immunosorbent assays for
routine diagnosis of arbovira l infect ions.
J Cli n Mic robiol 2000;38:1823-6.
Ca l is he r CH , K ar a ba ts os N, D al ry mp le 24.
JM, et al. Antigenic relationships between
f la vi viruses a s deter mi ned by cro ss-neu t ral -
ization test s with polyclonal ant isera. J G en
Virol 198 9;70:37-43.
Lanciotti RS, Ca lisher CH, Gubler DJ, 25.
Chang GJ, Vornda m AV. Rapid detection
and ty pi ng o f de ng ue v ir us es f ro m cl in ic al
samples by using reverse transcriptase-
polymer ase chain reaction. J Clin Micro-
biol 19 92;30:545-51.
Nasci RS, Gottfried KL, Burkhalter KL, 26.
et a l. Comp ari son of ver o cel l pl aque assay,
TaqMan reverse transcriptase polymerase
chain react ion RNA assay, and VecTest an-
tig en a ssay for detec tion of West Nile virus
in field-collected mosquitoes. J A m Mosq
Control Assoc 2002;18:294-300.
Powers A M, Brault AC, Tesh RB, 27.
Weaver SC. Re-emerg ence of Ch ik ung un ya
The New England Journal of Medicine
Downloaded from nejm.org on December 26, 2015. For personal use only. No other uses without permission.
Copyright © 2009 Massachusetts Medical Society. All rights reserved.
Zika Virus Outbreak on Yap Island
n engl j med 360;24 nejm.org june 11, 2009
2543
and O’nyong-nyong viruses: evidence for
dis ti nct g eog rap hical l in eage s a nd d ist ant
evolutionar y relationships. J Gen Virol
2000;81:471-9.
Särndal C, Swensson B, Wret man J. 28.
Mo de l a ss is te d s ur ve y s am pl in g. Ne w Yo rk :
Springer-Verlag, 1992.
Särndal C-E, Lundström S. Estima-29.
tion in surveys with nonresponse. West
Sussex, United Kingdom: John Wi ley,
2005.
Halstead SB, Rojanasuphot S, Sang-30.
kaw ibha N. Ori gi na l antigenic sin in den-
gue. Am J Tr op Med Hyg 1983;32:154 -6.
Inouye S, Matsuno S, Tsuruk ubo Y. 31.
“Origina l antigenic sin” phenomenon in
exper imenta l fl av iv ir us infec t ion s of gui n-
ea pigs: st udi es by en zyme-li nked i mm uno -
sorbent assay. Microbiol Immunol 1984;
28 :5 69 -74 .
Mostashari F, Bunning ML, Kitsutani 32.
PT, e t a l. Epi dem ic We st N ile e nce phali ti s,
New York, 1999: results of a household-
based seroepidemiological survey. Lancet
2001;358:261-4.
Nogueira RM, Miagostov ich MP, Cav-33.
alcanti SM, Marzochi KB, Sch atzm ayr
HG. L evel s of Ig M ant ibod ies a gain st d en-
gue virus in R io de Janeiro, Brazil. Res
Virol 1992;143:423 -7.
Roehrig J T, Nash D, Mald in B, et al. 34.
Pe rsi ste nce of vir us-r eac tive ser um i mmu-
no gl obu li n M an ti bod y i n c onf i rm ed West
Nile virus encephalitis cases. Emerg In-
fect Dis 2003;9:376-9.
Prince HE, Tobler LH, Lapé-Nixon M, 35.
Foster GA, Stramer SL, Busch MP. Devel-
opment and persistence of West Nile vi-
rus-specif ic i mmunog lobulin M (IgM),
IgA, and IgG in vi remic blood donors. J
Cli n Mi cro biol 2005;43:4316 -20.
Busch MP, K leinm an SH, Tobler LH, 36.
et al. Virus and antibody dynamics in
acute West Nile virus infection. J Infect
Dis 2008;198:98 4-93.
Copyright © 2009 Massachusetts Medical Society.
p o s t i n g
presentations
a t
medical
m e e t i n g s
o n
t h e
i n t e r n e t
Posting an audio recording of an oral presentation at a medical meeting on the
Internet, with selected slides from the presentation, will not be considered prior
publication. This will allow students and physicians who are unable to attend the
meeting to hear the presentation and view the slides. If there are any questions
about this policy, authors should feel free to call the Journal’s Editorial Offices.
The New England Journal of Medicine
Downloaded from nejm.org on December 26, 2015. For personal use only. No other uses without permission.
Copyright © 2009 Massachusetts Medical Society. All rights reserved.
... ZIKV was first identified in 1947 in a rhesus monkey in the Kampala and U regions of the African continent [10,[34][35][36][37][38][39][40] and isolated in 1948 in A. africanus mosq in the same area [16,41]. Five years after the virus was isolated [10,41], the African nent experienced its first ZIKV epidemic [10,[40][41][42][43]. ...
... Furthermore, with the wider scope of studies, countries in Asia such as India nesia, Malaysia, Pakistan, Philippines, Thailand, and Vietnam reported cases of ZIK tween the years 1950 and 1980 [16,[45][46][47][48][49]. After six decades, ZIKV was reported o the African and Asian continents, affecting approximately three quarters of the p tion of the Yap Islands, located in the Confederated States of Micronesia in the w Pacific Ocean, in 2007 [16,37]. The strain that caused this outbreak was identified classic Asian strain [11,16]. ...
... The transmission cycle of Zika virus (ZIKV) involves arthropods belonging to the Aedes genus: Aedes aegypti, Aedes albopictus, Aedes hensili, and Aedes polynesiensis [17,[63][64][65][66], as well as the domesticated mosquito Culex quinquefasciatus [10,22,67], rhesus monkeys [10,[34][35][36][37][38][39][40], and humans. The enzootic cycle of the disease occurs between mosquitoes and primates, including monkeys, chimpanzees, and baboons. ...
Article
Full-text available
Zika virus (ZIKV) is a mosquito-borne flavivirus of the family Flaviviridae. The association between ZIKV and microcephaly was first described in Brazil in 2015. The risk of vertical transmission occurs in pregnant women with or without symptoms, and the risk of malformation appears to be worse when infection occurs in the first and second trimesters of pregnancy. The rate of vertical transmission varies from 26 to 65%, and not all fetuses develop malformations. The incidence of malformations resulting from transmission is uncertain, ranging from 6–8% in the US to 40% in Brazil. Congenital ZIKV syndrome is a set of clinical manifestations that can affect the fetus of a mother infected with ZIKV. The manifestations are broad and nonspecific, including microcephaly, subcortical calcifications, ocular changes, congenital contractures, early hypertension, and pyramidal and extrapyramidal signs. Other findings such as growth restriction and fetal miscarriage/death may also occur. Our aim in this article is to review the literature on mosquito transmission, clinical presentation, serologic diagnosis, intrauterine transmission, pre- and postnatal imaging diagnostic findings, and short- and long-term follow-up.
... The first well-known outbreak of the ZIKV occurred in the Yap Islands of Micronesia in 2007. According to local public health reports, the Zika infection rate ranged from 73%, (4) the outbreak of French Pol-ynesia in 2013-14 followed by general prevalence rates of 49% with an estimated 32,000 infected patients between October 2013 and April 2014. (5,6) In the Brazilian outbreak, neurological disorders such as Guillain-Barré syndrome in adults reported an incidence between April-July 2015 among those ≥ 12 years of age was 5.6 cases/100,000 population/year and increased markedly with increasing age to 14.7 cases/100,000 among those ≥ 60 years of age. ...
Article
Full-text available
The 2015-16 Zika virus (ZIKV) epidemic has posed unprecedented concern for maternal-infant health, mainly due to the substantial risk of microcephaly and other neurological birth abnormalities associated with congenital ZIKV syndrome (CZS). As licenced vaccines and effective antivirals are still unavailable, attention has been focused on post-delivery in vitro or translational in vivo studies to understand the impact of maternal ZIKV infection on placentation and neurodevelopmental consequences for the foetus. Here, we review clinical and translational studies highlighting ZIKV-induced maternal-foetal interface dysfunction, adding to our previous observations of experimental ZIKV vertical transmission to pregnant rhesus monkeys and newly published post-epidemic findings about the theme. This comparative review focuses on the mechanisms by which the virus has a cytopathic effect on trophoblasts and macrophages during placentation in humans, nonhuman primates, and rodent transgenic models, crosses the placental barrier, replicates, and establishes a persistent uteroplacental infection. When considering the mechanism of ZIKV-induced birth defects in humans and other susceptible hosts, it becomes apparent how the various stages of the ZIKV cycle in the host (both the parent and offspring) unfold. This understanding presents specific opportunities for pharmacological intervention and the development of preventative vaccines.
... The results of a phylogenetic analysis of African and Southeast Asian ZIKAV isolates showed that a geographically distinct lineage of ZIKAV was introduced into SEA regions rather than the African genotype [28]. In 2007, a massive outbreak of ZIKAV was reported from Yap Island, Micronesia; this outbreak affected many people [49]. The virus that caused the outbreak on Yap Island was closely related to the Asian lineage which had been circulating in SEA. ...
Article
Full-text available
ZIKA fever (ZIKAF) is an emerging mosquito-borne flavivirus illness in humans. Regarding the etiological agent, ZIKA virus (ZIKAV), though it is known to be distributed in the tropics, causing sporadic cases, its rapid global expansion with pandemic potential has raised global concern. Due to its abrupt emergence in South American countries, the Caribbean, and the Americas, the WHO declared ZIKA a public health emergency of international concern in 2016. ZIKAV usually causes mild infections; however, its recent unusual presentations of Guillen–Barré syndrome in adults and microcephaly in newborn babies of ZIKAV-infected mothers in Brazil has caused concern among global public health authorities. Certain mutations on virus genomes have been found to be correlated with clinical severity, and its unusual transmission routes through sexual and blood transfusions emphasize the necessity for understanding its virological determinants and impact. Its abrupt re-emergence in India (2018–2019), particularly in Gujarat (2016), Tamil Nadu (2017), Uttar Pradesh (2021), Maharashtra, Kerala (2021), and Karnataka (2023), has indicated the need for urgent measures to strengthen surveillance systems and design effective prevention and control measures in this country. Given the global concern around ZIKAV, here, we reviewed current knowledge about global ZIKAV genetic lineages vis à vis the situation in India and discussed future priorities for ZIKAV research in India for effectively designing control strategies.
... For this equation, some global estimates were taken following an earlier study [59, Appendix Table 1]. The proportion (18%) of Zika cases which are symptomatic and median duration of symptoms (4.5 days, a rough mean of the figures 3.5 and 6 days listed for different symptoms) were taken from an early report from Micronesia [60]. As a proxy for the proportion of individuals who would seek medical care for a simple acute case we use the proportion (60%) of individuals in a household survey in Venezuela who said they would seek medical care for a suspected dengue case [61]. ...
Article
Full-text available
The complex immune interactions produced by the tetravalent dengue vaccine Dengvaxia have foregrounded the important role of antibody-dependent enhancement (ADE) in dengue infection. Some evidence exists that ADE may extend beyond the four dengue serotypes to Zika, a closely related flavivirus transmitted by the same mosquito species as dengue, and may also account for the increased severity of some cases. Estimates of the public health impact of dengue vaccination may then need to include its effects on the transmission of Zika in addition to dengue. This study gathers primary references to build estimates of per-case economic cost and disease burden for dengue and Zika infection with and without ADE in the ten countries where clinical trials were held for Dengvaxia, under the hypothesis that severe outcomes are associated with ADE of disease. From these estimates, per-infection weighted averages are developed (without assumptions on transmission dynamics or case totals) which will facilitate population-level estimates of the potential impact of dengue vaccination on a dual outbreak using mathematical modeling. Results estimate that ADE amplifies the per-case toll of dengue by a factor of 2–16 but increases that of a Zika case by more than two orders of magnitude due to the greater risk of severe consequences. As expected, dengue vaccination affects per-infection dengue toll much more when high prior dengue seropositivity involves a different serotype than the one(s) circulating, but that same high dengue seropositivity makes vaccination exacerbate Zika toll less.
... Os primeiros casos no Brasil são datados de 2015, onde a infecção é através da picada de fêmeas infectadas do gênero Aedes, sendo Ae. aegypti o principal vetor no país (Campos et al., 2015). Os sintomas característicos são febre, dores articulares, mialgia, dores de cabeça, conjuntivite e manchas vermelhas no corpo (Duffy et al., 2009 Ainda pode ocorrer em casos graves (menos de 1%), a ocorrência de meningite e encefalite, com possibilidade de evoluir para óbito (Murray et al., 2010;Sejvar et al., 2014). O vírus tem como hospedeiros equinos e o homem, no Brasil o primeiro relato no homem ocorreu em 2014, no Piauí (Ometto et al., 2013). ...
Article
Introduction: Brazil, with its vast territorial extension and high population density, has a significant occurrence of arboviruses, such as dengue, zika and chikungunya. These diseases, which are widely reported in different regions, share similar symptoms, which makes diagnosis and control difficult, negatively impacting the public health system. The main vector of these diseases is the Aedes aegypti mosquito, making its population control a priority in prevention strategies. Objective: This review article aimed to analyze the main arboviruses circulating in Brazil, discuss the factors associated with the increase in their incidence, and highlight the relevance of basic sanitation as a prevention tool. Methodology: For the preparation of this work, an integrative literature review was carried out in scientific databases, including articles published between 2000 and 2023. Studies that address the epidemiology, vectors, risk factors, impact on public health, and control measures of arboviruses in Brazil were selected. Data on public policies for basic sanitation and their relationship with the incidence of these diseases were also analyzed. Results and Discussion: The analysis revealed that the high incidence of arboviruses is associated with factors such as inadequate sanitation conditions, water storage practices in areas with limited access to regular supply, and climate change. Studies indicate that regions with lower basic sanitation coverage have a higher prevalence of mosquito vector foci. The review also highlighted the importance of integrated control measures, such as environmental management, the use of biological and chemical technologies, and public awareness, as strategies to reduce the proliferation of Aedes aegypti and the number of cases. Conclusion: The fight against arboviruses in Brazil requires investments in basic sanitation infrastructure, targeted public policies and educational actions that encourage the elimination of mosquito breeding grounds. The implementation of integrated strategies can minimize the impact of these diseases on public health and improve the quality of life of the population.
... Following the initial outbreak activity in the Federated States of Micronesia in 2007, a large outbreak began in French REVIEW OF RECENT EPIDEMIOLOGY OF ZIKA VIRUS Polynesia in 2013, and sporadic cases, small clusters, and outbreaks of Zika were reported by health ministries in various other Pacific Island countries (PICs) in subsequent years. 82,83 Some increased reporting also occurred in larger countries in the region, likely related to improved awareness and increased testing. Though infrequent, probable and confirmed cases of ZIKV-associated microcephaly and CZS have been reported from Cambodia, French Polynesia, Lao People's Democratic Republic, and Viet Nam. ...
Article
Full-text available
Zika virus (ZIKV) is a flavivirus transmitted primarily by the bite of infected Aedes species mosquitoes. Although typically asymptomatic or causing mild symptoms and infrequent neurological disease in older children and adults, infection during pregnancy can result in severe congenital malformations and neurodevelopmental deficits. We conducted a review of published literature and official data sources to describe recent Zika epidemiological trends, building on WHO updates posted in 2019 and 2022. Globally, cases declined after the height of ZIKV transmission in the Americas in 2015–2016; however, transmission continues across multiple regions, with intermittent outbreaks reported. As of December 2023, there is documented evidence of current or prior autochthonous mosquito-borne ZIKV transmission in 92 countries and territories; most recently, Guinea, Mali, and Sri Lanka were included on the basis of recent or retrospective testing of specimens collected during surveillance activities or studies. The abundance of asymptomatic and mild infections and limited diagnostic testing suggest that transmission in many locations likely remains underrecognized. Public health authorities, clinicians, communities at risk, and travelers should remain alert to the possibility of ZIKV transmission and implement measures to limit the risk of infection with ZIKV and other Aedes -borne arboviruses. To strengthen surveillance for ZIKV infections and congenital disease, targeted surveillance using clear case definitions and epidemiologically appropriate laboratory testing algorithms should be applied.
Article
Full-text available
Infection with the Zika virus (ZIKV) poses a threat to human health. An improved understanding of the host Toll-like receptor response, disease onset, and viral clearance in vivo and in vitro may lead to the development of therapeutic or prophylactic interventions against viral infections. Currently, no clinically approved ZIKV vaccine is available, highlighting the need for its development. In this study, we discuss the progress in the Zika vaccine, including advances in the use of Toll-like receptor agonists as vaccine adjuvants to enhance vaccine efficacy.
Article
A series of epidemic models with asymptomatic infection and transmission heterogeneity are progressively developed and discussed in this paper. The aim is to explore the effect of asymptomatic infections and their management on disease dynamics. The effective reproductive numbers of three models are derived, and their global dynamical properties are proven by constructing appropriate Lyapunov functions. The sensitivity analysis of effective reproduction numbers is obtained by the PRCC method. The comparative result shows that the relevance of transmission, hospitalization and recovery rates of symptomatic patients weaken dramatically when asymptomatic infection is considered. Meanwhile, differences in the sensitivity of influences associated with asymptomatic infections further confirm transmission heterogeneity. It also reveals that vaccine coverage is a crucial factor that affects the dynamics of disease. Additionally, this study examines numerical simulations to assess the effectiveness of various sensitivity-related interventions. Both theoretical and numerical results consistently reveal that neglecting asymptomatic infection will underestimate the extent of infections. Moreover, considering the transmission heterogeneity of asymptomatic infection and strengthening the management for higher-transmission subgroup, can minimize critical vaccination coverage and achieve disease control.
Article
Full-text available
Zika virus (ZIKV) is unique among orthoflaviviruses in its vertical transmission capacity in humans, yet the underlying mechanisms remain incompletely understood. Here, we show that ZIKV induces tunneling nanotubes (TNTs) in placental trophoblasts which facilitate transfer of viral particles, proteins, mitochondria, and RNA to neighboring uninfected cells. TNT formation is driven exclusively via ZIKV non-structural protein 1 (NS1). Specifically, the N-terminal 1-50 amino acids of membrane-bound ZIKV NS1 are necessary for triggering TNT formation in host cells. Trophoblasts infected with TNT-deficient ZIKVΔTNT mutant virus elicited a robust antiviral IFN-λ 1/2/3 response relative to WT ZIKV, suggesting TNT-mediated trafficking allows ZIKV cell-to-cell transmission camouflaged from host defenses. Using affinity purification-mass spectrometry of cells expressing wild-type NS1 or non-TNT forming NS1, we found mitochondrial proteins are dominant NS1-interacting partners. We demonstrate that ZIKV infection or NS1 expression induces elevated mitochondria levels in trophoblasts and that mitochondria are siphoned via TNTs from healthy to ZIKV-infected cells. Together our findings identify a stealth mechanism that ZIKV employs for intercellular spread among placental trophoblasts, evasion of antiviral interferon response, and the hijacking of mitochondria to augment its propagation and survival and offers a basis for novel therapeutic developments targeting these interactions to limit ZIKV dissemination.
Article
Full-text available
The dynamics of the early stages of West Nile virus (WNV) infection can be assessed by follow-up studies of viremic blood donors. A total of 245 donors with WNV viremia were followed up weekly for 4 weeks and then monthly for up to 6 additional months or until seroconversion. Plasma samples were tested for WNV RNA by transcription-mediated amplification (TMA) and for WNV-specific IgM and IgG antibodies. RNA persistence was investigated by 6 replicate TMA tests; samples that were viremic for >40 days were tested for WNV-neutralizing activity. Follow up of 35 additional viremic donors for up to 404 days was conducted to evaluate persistence of WNV-specific antibody. The median time from RNA detection to IgM seroconversion was 3.9 days; to IgG seroconversion, 7.7 days; to RNA negativity by single-replicate TMA, 13.2 days; and to RNA negativity by 6-replicate TMA, 6.1 additional days after results of single-replicate TMA are negative. For 4 donors in whom RNA persisted for >40 days after the index donation, all samples obtained after this threshold were also positive for WNV IgG and neutralizing activity. The mean times to IgM and IgA negativity were 156 and 220 days, respectively. IgM and IgG develop rapidly after viremia and before RNA levels become undetectable, which occurred a mean of 13.2 days after the index donation among donors in this study. WNV RNA detection by replicate TMA rarely persists for >40 days after the index donation and is accompanied by WNV-specific neutralizing antibody, consistent with an absence of WNV transmission via transfusion of seropositive blood components.
Article
Full-text available
Zika virus (ZIKV) is a mosquito-borne flavivirus first isolated in Uganda from a sentinel monkey in 1947. Mosquito and sentinel animal surveillance studies have demonstrated that ZIKV is endemic to Africa and Southeast Asia, yet reported human cases are rare, with <10 cases reported in the literature. In June 2007, an epidemic of fever and rash associated with ZIKV was detected in Yap State, Federated States of Micronesia. We report the genetic and serologic properties of the ZIKV associated with this epidemic.
Article
Around the world a multitude of surveys are conducted every day, on a variety of subjects, and consequently surveys have become an accepted part of modern life. However, in recent years survey estimates have been increasingly affected by rising trends in nonresponse, with loss of accuracy as an undesirable result. Whilst it is possible to reduce nonresponse to some degree, it cannot be completely eliminated. Estimation techniques that account systematically for nonresponse and at the same time succeed in delivering acceptable accuracy are much needed. Estimation in Surveys with Nonresponse provides an overview of these techniques, presenting the view of nonresponse as a normal (albeit undesirable) feature of a sample survey, one whose potentially harmful effects are to be minimised. Builds in the nonresponse feature of survey data collection as an integral part of the theory, both for point estimation and for variance estimation. Promotes weighting through calibration as a new and powerful technique for surveys with nonresponse. Highlights the analysis of nonresponse bias in estimates and methods to minimize this bias. Includes computational tools to help identify the best variables for calibration. Discusses the use of imputation as a complement to weighting by calibration. Contains guidelines for dealing with frame imperfections and coverage errors. Features worked examples throughout the text, using real data. The accessible style of Estimation in Surveys with Nonresponse will make this an invaluable tool for survey methodologists in national statistics agencies and private survey agencies. Researchers, teachers, and students of statistics, social sciences and economics will benefit from the clear presentation and numerous examples.
Article
One of the authors contracted a Zika virus infection during laboratory work. Subsequent studies revealed an immunological response of the anamnestic type due to preceding yellow fever vaccinations which rendered difficult etiological diagnosis had it not been possible to isolate the virus from the serum sample collected during the acute phase of the disease. The authors comment on the possible importance of similar cases encountered in tropical countries when dignosis is based merely on the serological conversion from the acute phase to the convalescent phase of the disease.
Article
Incl. bibliographical references, index
Article
A study of Zika virus infections was carried out in four communities in Oyo State, Nigeria. Virus isolation studies between 1971 and 1975 yielded two virus isolations from human cases of mild febrile illness. Haemagglutination-inhibition tests revealed a high prevalence of antibodies to Zika and three other flaviviruses used. The percentages of positive sera were as follows: Zika (31%), Yellow fever (50%), West Nile (46%), and Wesselsbron (59%). Neutralization tests showed that 40% of Nigerians had Zika virus neutralizing antibody. Fifty per cent of zika virus immune persons had neutralizing antibody to Zika alone or to Zika and one other flavivirus. A total of 121 sera had antibody to Zika virus; of these 48 (40%) also showed antibody to two other flaviviruses, and 12 (10%) had antibodies to three or more other viruses. The percentage of neutralizing antibodies to other flaviviruses in Zika virus immune sera was 81% to Dengue type 1, 58% to Yellow fever, 7% to Wesselsbron, 6% to West Nile and 3% to Uganda S.
Article
Serological studies for arbovirus antibodies were carried out on 1.279 human serum specimens collected from adults in south-eastern part of Gabon from June to September 1975 during a multipurpose epidemiological survey. More than 80% of the population surveyed have neutralizing antibodies for yellow fever virus as consequence of mass vaccination campaign. Chikungunya, Zika, Wesselsbron and Koutango virus showed some activity, especially in woodland savannahs.
Article
A study of arbovirus infections occurring in Igbo-Ora community was carried out between May and October 1975. Haemagglutination inhibition test performed on seventy-eight human sera showed a high prevalence of antibodies against all the six arboviruses used. Percentage of positive sera were as follows: Chikungunya, (28%); Yellow fever (36%); Dengue type 1 (67%); Dengue type 2 (45%). Prevalence of HI antibodies to West Nile and Wesselsbron viruses were 44% and 59% respectively. Virus isolation studies carried out on 148 blood samples yielded three viruses: Yellow fever, Dengue type 1 and Zika. Antibody conversions to these three viruses were demonstrated in seven persons within the period of study.
Article
During the years 1964 to 1970, 171 arboviruses of 15 different types were isolated from humans in Nigeria. Isolation rates were highest in 1969, and lowest in 1965 and 1967. Monthly arbovirus activity was highest in the rainy season months of June, July and August and lowest in the dry months of January and February. Viruses were isolated from all age groups, with the majority from children one to four years old. The viruses isolated in largest numbers were chikungunya and yellow fever, which caused epidemics in 1969, and dengue types 1 and 2 and Tataguine, which are endemic in Ibadan. Bwamba virus was isolated in 1964 and 1969, and Bunyamwera group viruses were encountered for the first time in 1969. Other viruses recovered less frequently were Zika, Igbo-Ora (an agent related to o'nyong-nyong), two viruses related to the Uganda mosquito virus Ug MP 359, Dugbe, Thogoto, Lebombo and Shuni. Several of these are new agents and have not previously been isolated from man. Clinical details are presented where available.
Article
The appearance and persistence of IgM antibodies were studied by MAC-ELISA in 926 confirmed cases of dengue virus type 1 infection. Assays performed on acute and convalescent patient sera revealed that IgM antibodies appeared during the early phase of disease (day 2) and persisted for three months after onset. MAC-ELISA proved to be a valuable early diagnosis test when compared with haemagglutination inhibition.